Table 6.
Proportion of Individuals Recommended Statin Therapy According to Concordant and Discordant Recommendations, by Selected Characteristics
| Concordant Recommendations | Discordant Recommendations | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neither Recommended Statin Therapy | Both Recommended Statin Therapy | Recommended by CCS Guidelines but Not ACC-AHA | Recommended by ACC-AHA Guidelines but Not CCS | |||||||||
| Column | A | 95% CI | B | 95% CI | C | 95% CI | D | 95% CI | ||||
| Population (millions) | 7.6 | 7.1 | 8.1 | 3.8 | 3.3 | 4.3 | 1.1 | 0.8 | 1.3 | 0.5 | 0.3 | 0.6 |
| Proportion, % | 58.5 | 54.8 | 62.0 | 29.1 | 26.0 | 32.5 | 8.5 | 7.0 | 10.3 | 3.9 | 2.9 | 5.1 |
| Age group, % | ||||||||||||
| 40 to 59 y | 88.2 | 85.7 | 90.2 | 41.3 | 35.4 | 47.4 | 82.6 | 76.0 | 87.8 | † | NA | NA |
| 60 to 75 y | 11.8 | 9.8 | 14.3 | 58.7 | 52.6 | 64.6 | 17.4 | 12.2 | 24.0 | 80.1 | 61.9 | 90.9 |
| Sex, % | ||||||||||||
| Men | 37.9 | 35.0 | 41.0 | 64.4 | 60.0 | 68.5 | 51.8 | 40.7 | 62.8 | 65.8 | 54.2 | 75.8 |
| Women | 62.1 | 59.0 | 65.0 | 35.6 | 31.5 | 40.0 | 48.2 | 37.2 | 59.3 | 34.2 | 24.2 | 45.8 |
| Daily or occasional smoker, % | 19.9 | 15.9 | 24.6 | 24.2 | 18.0 | 31.7 | 19.7* | 12.4 | 30.0 | 28.2* | 16.1 | 44.6 |
| Diabetes, % | 0.0 | NA | NA | 29.9 | 23.8 | 36.9 | 0.0 | NA | NA | 0.0 | NA | NA |
| Chronic kidney disease, % | 0.0 | NA | NA | 10.6* | 7.3 | 15.2 | 16.5* | 9.5 | 27.0 | 0.0 | NA | NA |
| Hypertensive, % | 9.0 | 6.9 | 11.6 | 67.6 | 60.8 | 73.7 | 28.7 | 20.6 | 38.5 | 42.0 | 29.5 | 55.6 |
| Antihypertensive medication use, % | 7.9 | 5.9 | 10.5 | 62.6 | 54.4 | 68.3 | 24.3* | 16.6 | 34.0 | 32.9* | 20.7 | 47.9 |
| Family history of CVD at age ≤60 y, % | 16.2 | 13.6 | 19.2 | 21.4 | 17.1 | 26.4 | 47.8 | 37.2 | 58.6 | 15.2* | 7.9 | 27.3 |
| LDL cholesterol level ≥3.5 mmol/L, % | 32.1 | 28.1 | 36.4 | 74.0 | 65.7 | 81.4 | 79.9 | 70.2 | 87.1 | † | — | — |
Source: Combined 2007–2009 and 2009–2011 Canadian Health Measures Survey.
ACC-AHA, American College of Cardiology and American Heart Association; CI, confidence interval; CSS, Canadian Cardiovascular Society; CVD, cardiovascular disease; LDL, low-density lipoprotein; NA, not applicable.
*
Use with caution (coefficient of variation 16.6% to 33.3%). †Estimate suppressed due to small sample size.